136 results
Page 7 of 7
PRE 14A
ds3kis40wv
14 Mar 13
Preliminary proxy
12:00am
8-K
EX-1.1
kts1isv3702071g7
31 Jan 13
NewLink Genetics Corporation Announces Proposed Public Offering of Common Stock
12:00am
8-K
EX-99.1
kq60b
31 Oct 12
NewLink Genetics Corporation Reports Third Quarter 2012 Financial Results
12:00am
8-K
EX-99.1
ol240 o67f9
3 Oct 12
NewLink Genetics Launches Adaptive Design Phase 2B/3 Clinical Trial of tergenpumatucel-L Immunotherapy in Patients with Non-Small Cell Lung Cancer
12:00am
DEF 14A
19omke3b1 5v
21 Sep 12
Definitive proxy
12:00am
10-K/A
mdgl9 8aqjpw9n
27 Apr 12
Annual report (amended)
12:00am
10-K
bnhuw io70mcyer
30 Mar 12
Annual report
12:00am
8-K
EX-1
21xdn 8b15nah
29 Mar 12
Results of Operations and Financial Condition
12:00am
10-Q
ip8b35k3
16 Dec 11
Quarterly report
12:00am